161

Public Health & Prevention
Focuses on global human health and epidemic prevention.
Sub Categories on Public Health & Prevention
Latest Articles
A simple T-cell test to show the full picture of body's immune response to COVID-19

A simple T-cell test to show the full picture of body's immune response to COVID-19

by Duke-NUS Medical SchoolGraphical abstract. Credit: DOI: 10.1172/JCI152379Researchers from Duke-NUS Medical School, together with collaborators from the National Centre for Infectious Diseases

A simple T-cell test to show the full picture of body's immune response to COVID-19

by Duke-NUS Medical SchoolGraphical abstract. Credit: DOI: 10.1172/JCI152379Researchers from Duke-NUS Medical School, together with collaborators from the National Centre for Infectious Diseases
Gilead licenses HIV-prevention drug to generic drugmakers

Gilead licenses HIV-prevention drug to generic drugmakers

Credit: Pixabay/CC0 Public DomainUS pharmaceutical giant Gilead said Wednesday it had signed licensing deals with six generic drugmakers to produce and sell its HIV prevention medicine in lower-income

Gilead licenses HIV-prevention drug to generic drugmakers

Credit: Pixabay/CC0 Public DomainUS pharmaceutical giant Gilead said Wednesday it had signed licensing deals with six generic drugmakers to produce and sell its HIV prevention medicine in lower-income
Mutations do not predict the severity of current variants of SARS-CoV-2, finds study

Mutations do not predict the severity of current variants of SARS-CoV-2, finds study

byUniversity of North Carolina at CharlotteThe fragment antigen-binding region of the neutralizing antibody CV2.1169, shown on the left in red, in complex with the receptor binding domain of the

Mutations do not predict the severity of current variants of SARS-CoV-2, finds study

byUniversity of North Carolina at CharlotteThe fragment antigen-binding region of the neutralizing antibody CV2.1169, shown on the left in red, in complex with the receptor binding domain of the
An age-old battle: Scientists uncover what makes malaria such a wily foe

An age-old battle: Scientists uncover what makes malaria such a wily foe

by Lindzi Wessel, Chan Zuckerberg BiohubPhIP-seq overview and analysis pipeline. Falciparome phage library displays the proteome ofPlasmodium falciparumin 62-aa peptides with 25-aa step si

An age-old battle: Scientists uncover what makes malaria such a wily foe

by Lindzi Wessel, Chan Zuckerberg BiohubPhIP-seq overview and analysis pipeline. Falciparome phage library displays the proteome ofPlasmodium falciparumin 62-aa peptides with 25-aa step si
Vaccine to prevent a dangerous tropical disease receives approval

Vaccine to prevent a dangerous tropical disease receives approval

by Estonian Research CouncilWork in Tartu University's virology lab. Author Kaspar Koolmeister. Credit: Kaspar KoolmeisterThe chikungunya virus is widespread in tropical regions, where it is sprea

Vaccine to prevent a dangerous tropical disease receives approval

by Estonian Research CouncilWork in Tartu University's virology lab. Author Kaspar Koolmeister. Credit: Kaspar KoolmeisterThe chikungunya virus is widespread in tropical regions, where it is sprea
Two California dairy workers were infected with bird flu, latest human cases in US

Two California dairy workers were infected with bird flu, latest human cases in US

by Jonel AlecciaIn this photo provided by the U.S. Department of Agriculture, an animal caretaker collects a blood sample from a dairy calf vaccinated against bird flu in a containment building at the

Two California dairy workers were infected with bird flu, latest human cases in US

by Jonel AlecciaIn this photo provided by the U.S. Department of Agriculture, an animal caretaker collects a blood sample from a dairy calf vaccinated against bird flu in a containment building at the
A new class of antibodies against COVID-19 is being put to the test

A new class of antibodies against COVID-19 is being put to the test

by Garvan Institute of Medical ResearchStructural characterization of the broadly neutralizing class 1 antibody GAR05. a Cryo-EM structure of GAR05 Fab bound to trimeric spike (3.27 Å resolution)

A new class of antibodies against COVID-19 is being put to the test

by Garvan Institute of Medical ResearchStructural characterization of the broadly neutralizing class 1 antibody GAR05. a Cryo-EM structure of GAR05 Fab bound to trimeric spike (3.27 Å resolution)
US mpox cases rising again as vaccinations lag

US mpox cases rising again as vaccinations lag

by Robin FosterMpox cases are climbing again in the United States, with the number of reported infections now twice as high as they were at this time last year, new government data shows.In response,&

US mpox cases rising again as vaccinations lag

by Robin FosterMpox cases are climbing again in the United States, with the number of reported infections now twice as high as they were at this time last year, new government data shows.In response,&
Simple blood test could predict risk of long-term COVID-19 lung problems

Simple blood test could predict risk of long-term COVID-19 lung problems

by University of VirginiaComputerized tomography images of Early- and Late- Resolving COVID associated pulmonary fibrosis and study design. (A) CT images of two COVID survivors displaying resolvi

Simple blood test could predict risk of long-term COVID-19 lung problems

by University of VirginiaComputerized tomography images of Early- and Late- Resolving COVID associated pulmonary fibrosis and study design. (A) CT images of two COVID survivors displaying resolvi
New COVID-19 strategy: Vaccinate potential superspreaders first

New COVID-19 strategy: Vaccinate potential superspreaders first

by Macquarie UniversityCredit: Pixabay/CC0 Public DomainWith thousands of scientists around the world racing to develop a vaccine for COVID-19, policy makers may need to decide who is at the fron

New COVID-19 strategy: Vaccinate potential superspreaders first

by Macquarie UniversityCredit: Pixabay/CC0 Public DomainWith thousands of scientists around the world racing to develop a vaccine for COVID-19, policy makers may need to decide who is at the fron
SARS-CoV-2 infections may trigger antibody responses against multiple virus proteins

SARS-CoV-2 infections may trigger antibody responses against multiple virus proteins

by Public Library of ScienceCredit: Pixabay/CC0 Public DomainAll coronaviruses produce four primary structural proteins and multiple nonstructural proteins. However, the majority of antibody-base

SARS-CoV-2 infections may trigger antibody responses against multiple virus proteins

by Public Library of ScienceCredit: Pixabay/CC0 Public DomainAll coronaviruses produce four primary structural proteins and multiple nonstructural proteins. However, the majority of antibody-base
Clues to COVID-19 complications come from NET-like inflammatory response

Clues to COVID-19 complications come from NET-like inflammatory response

by University of Utah Health SciencesUniversity of Utah Health critical care specialist Elizabeth Middleton, MD, treats patients with COVID-19 in the intensive care unit. A research team includin

Clues to COVID-19 complications come from NET-like inflammatory response

by University of Utah Health SciencesUniversity of Utah Health critical care specialist Elizabeth Middleton, MD, treats patients with COVID-19 in the intensive care unit. A research team includin